CEO
Tilda Research
Ram Yalamanchili is an accomplished medical innovator and entrepreneur. As Founder & CEO of Tilda Research, Ram has pioneered a new operating model for Tilda’s clinical site network through the development of workflow management and automation technologies. Prior to Tilda, Ram served as Co-Founder & CTO at Lexent Bio, where he led a team that made advances in liquid biopsy technologies, improving cancer diagnostics. This promising work led to the acquisition of Lexent by Roche. In addition to his medical innovations, Ram is an experienced technology entrepreneur. He co-founded & served as CEO of Push Computing, one of the first companies to introduce predictive security for mobiles. Push Computing was acquired by MobileIron, where Ram helped guide the company through a successful IPO. Prior to that, Ram was an early engineer at VMware, where he was instrumental in helping build the company from an initial product to a successful public listing over his nearly decade-long tenure. Academically, Ram holds credentials from both Stanford University and Carnegie Mellon University, with a focus on Management Science and Engineering, and Electrical and Computer Engineering respectively. Previously, Ram served on the board of the San Diego Blood Bank, reflecting his commitment to healthcare and service.